home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

NICHD Launches Project to Treat Infant Asphyxia In Lower Income Countries

  April, 7 2005 22:18
your information resource in human molecular genetics
Newborn asphyxia — an infant’s failure to begin or sustain breathing — is a serious problem in resource poor countries where births do not occur in a health care facility and where birth attendants are not trained in newborn resuscitation. In the United States and more developed regions of the world, trained health care professionals can rapidly take steps to treat asphyxia.

The project will be undertaken by the Global Network for Women’s and Children’s Health Research, which is sponsored by the National Institute of Child Health and Human Development of the National Institutes of Health, in partnership with the Bill and Melinda Gates Foundation.

The new project seeks to determine if training midwives and other traditional birth attendants in standard infant resuscitation practices commonly used in the United States can reduce the death and disability from newborn asphyxia in resource poor settings.

The Network project was announced on World Health Day April 7, 2005.

More information can be found at NIH News.

Message posted by: Rashmi Nemade

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.